DermBiont is a Biotech company based in Boston. It has raised $73M in total funding. Latest round: Series B.
DermBiont funding overview
DermBiont is a Biotech company based in Boston. DermBiont has raised $73M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series B announced in October 2023. The round record for DermBiont runs through 2023; nothing later has been disclosed. Investors on record include Civilization Ventures, Double Point Ventures, Olive Tree Capital, Viking Global Investors, Pivotal Life Sciences, Toba Capital. 6 distinct backers are named across the disclosed rounds.
DermBiont at a glance
Total raised
$73M
Latest round
Series B
Latest round date
October 2023
Industry
Biotech
Headquarters
Boston
Notable investors
Civilization Ventures, Double Point Ventures, Olive Tree Capital, Viking Global Investors, Pivotal Life Sciences, Toba Capital
Frequently asked about DermBiont funding
How much has DermBiont raised?
DermBiont has raised $73M in total disclosed funding across the rounds on record.
Who has invested in DermBiont?
Civilization Ventures, Double Point Ventures, Olive Tree Capital, Viking Global Investors, Pivotal Life Sciences, Toba Capital are named among the investors backing DermBiont.
What was the latest DermBiont funding round?
The most recent disclosed round is a Series B, announced in October 2023.
Where is DermBiont based?
DermBiont is based in Boston.
What sector does DermBiont operate in?
DermBiont is tracked under Biotech from Boston, with $73M in disclosed funding.
When did DermBiont last raise?
The last disclosed DermBiont round closed in October 2023 at Series B.
Every DermBiont figure above comes from filings and announced rounds in the StartupFundraising company database and is revised as new rounds are recorded. The lists below compare Biotech companies in Boston at a similar stage.
